Literature DB >> 12218097

Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.

Thomas S Söderström1, Minna Poukkula, Tim H Holmström, Kaisa M Heiskanen, John E Eriksson.   

Abstract

Fas ligand and TNF-related apoptosis-inducing ligand (TRAIL) induce apoptosis in many different cell types. Jurkat T cells die rapidly by apoptosis after treatment with either ligand. We have previously shown that mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) can act as a negative regulator of apoptosis mediated by the Fas receptor. In this study we examined whether MAPK/ERK can also act as a negative regulator of apoptosis induced by TRAIL. Activated Jurkat T cells were efficiently protected from TRAIL-induced apoptosis. The protection was shown to be MAPK/ERK dependent and independent of protein synthesis. MAPK/ERK suppressed TRAIL-induced apoptosis upstream of the mitochondrial amplification loop because mitochondrial depolarization and release of cytochrome c were inhibited. Furthermore, caspase-8-mediated relocalization and activation of Bid, a proapoptotic member of the Bcl family, was also inhibited by the MAPK/ERK signaling. The protection occurred at the level of the apoptotic initiator caspase-8, as the cleavage of caspase-8 was inhibited but the assembly of the death-inducing signaling complex was unaffected. Both TRAIL and Fas ligand have been suggested to regulate the clonal size and persistence of different T cell populations. Our previous results indicate that MAPK/ERK protects recently activated T cells from Fas receptor-mediated apoptosis during the initial phase of an immune response before the activation-induced cell death takes place. The results of this study show clearly that MAPK/ERK also participates in the inhibition of TRAIL-induced apoptosis after T cell activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218097     DOI: 10.4049/jimmunol.169.6.2851

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques.

Authors:  Jessica E Taaffe; Steven E Bosinger; Gregory Q Del Prete; James G Else; Sarah Ratcliffe; Christopher D Ward; Thi Migone; Mirko Paiardini; Guido Silvestri
Journal:  J Med Primatol       Date:  2011-11-14       Impact factor: 0.667

2.  Proteasome inhibition can impair caspase-8 activation upon submaximal stimulation of apoptotic tumor necrosis factor-related apoptosis inducing ligand (TRAIL) signaling.

Authors:  Maike A Laussmann; Egle Passante; Christian T Hellwig; Bartlomiej Tomiczek; Lorna Flanagan; Jochen H M Prehn; Heinrich J Huber; Markus Rehm
Journal:  J Biol Chem       Date:  2012-03-09       Impact factor: 5.157

3.  The role of TRADD in TRAIL-induced apoptosis and signaling.

Authors:  Xiumei Cao; Yelena L Pobezinskaya; Michael J Morgan; Zheng-gang Liu
Journal:  FASEB J       Date:  2010-12-27       Impact factor: 5.191

Review 4.  Life and death by death receptors.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

Review 5.  RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loop.

Authors:  Benjamin Bonavida
Journal:  Crit Rev Oncog       Date:  2014

6.  Hydrogen peroxide activation of ERK5 confers resistance to Jurkat cells against apoptosis induced by the extrinsic pathway.

Authors:  Takeshi Suzuki; Jay Yang
Journal:  Biochem Biophys Res Commun       Date:  2014-01-22       Impact factor: 3.575

Review 7.  Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.

Authors:  Olaf Hoffmann; Frauke Zipp; Joerg R Weber
Journal:  J Mol Med (Berl)       Date:  2009-05-17       Impact factor: 4.599

8.  TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects.

Authors:  Vinh Nguyen; Cornelia Cudrici; Valentina Zernetkina; Florin Niculescu; Horea Rus; Cynthia Drachenberg; Violeta Rus
Journal:  Clin Immunol       Date:  2009-04-05       Impact factor: 3.969

9.  Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins.

Authors:  Sojung Park; Dong Hyung Cho; Ladislav Andera; Nayoung Suh; Inki Kim
Journal:  Mol Cell Biochem       Date:  2013-07-12       Impact factor: 3.396

Review 10.  Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussion.

Authors:  Sarah Shirley; Alexandre Morizot; Olivier Micheau
Journal:  Recent Pat Anticancer Drug Discov       Date:  2011-09       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.